Which has grown faster, ADUS or URGN?

Over the past five years, URGN grew revenue faster — ADUS at a 12.67% CAGR versus URGN at 42.66%.

Is ADUS or URGN more profitable?

ADUS runs the higher net margin — ADUS at 7.13% versus URGN at -51.73%.

How have ADUS and URGN total returns compared?

Over the past 5 years, ADUS delivered 8.33% and URGN delivered 20.32% annualized total return. Past performance doesn't predict future results.

Addus HomeCare Corporation (ADUS) vs UroGen Pharma Ltd. (URGN)

A side-by-side comparison of Addus HomeCare Corporation and UroGen Pharma Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADUS

Addus HomeCare Corporation

$2.11B

$113.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

URGN

UroGen Pharma Ltd.

$2.02B

$41.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ADUS vs URGN

growth of $100 · dividends reinvested · last 9y

ADUS +226.5% (+14.1%/yr)URGN +206.0% (+13.2%/yr)ADUS compounded faster over this window

ADUS URGN

ADUS vs URGN: by the numbers

•ADUS is the larger company ($2.11B vs $2.02B market cap).
•ADUS is profitable (7.13% net margin) while URGN runs a net loss (-51.73%).
•URGN grew revenue faster over the past five years (42.66% vs 12.67% CAGR).

Metrics side by side

Valuation

Metric	ADUS	URGN
P/E ratio	19.85	N/A
Forward P/E	16.06	N/A
PEG ratio	0.98	N/A
P/S ratio	1.43	10.70
P/B ratio	1.84	N/A
EV / EBITDA	12.86	N/A
FCF yield	7.25%	N/A

Profitability

Metric	ADUS	URGN
Gross margin	32.36%	90.85%
Operating margin	10.04%	-113.73%
Net margin	7.13%	-51.73%
ROE	9.17%	N/A
ROIC	8.61%	-34.96%

Growth (annualized)

Metric	ADUS	URGN
Revenue CAGR (5Y)	12.67%	42.66%
EPS CAGR (5Y)	19.61%	N/A
FCF CAGR (5Y)	24.41%	N/A
Total return CAGR (5Y)	8.33%	20.32%

Frequently asked

Which has grown faster, ADUS or URGN?: Over the past five years, URGN grew revenue faster — ADUS at a 12.67% CAGR versus URGN at 42.66%.
Is ADUS or URGN more profitable?: ADUS runs the higher net margin — ADUS at 7.13% versus URGN at -51.73%.
How have ADUS and URGN total returns compared?: Over the past 5 years, ADUS delivered 8.33% and URGN delivered 20.32% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADUS analysis Full URGN analysis Interactive comparison tool

Dig into the metrics

Addus HomeCare P/E ratio Addus HomeCare ROE UroGen Pharma ROE Addus HomeCare operating margin UroGen Pharma operating margin Addus HomeCare revenue growth UroGen Pharma revenue growth Addus HomeCare free cash flow UroGen Pharma free cash flow

Addus HomeCare & UroGen Pharma appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.